All Current Publications
Document Type
Factsheet
Publisher
Utah State University Extension
Publication Date
4-23-2020
First Page
1
Last Page
7
Abstract
Death by drug poisoning is the leading cause of death due to injury in the state of Utah (UDOH, 2014). From 2013-2015, Utah ranked seventh in the nation for drug overdose deaths, the majority of which were opioid-related (CDC, 2018a). In 2017, the age-adjusted mortality rate from drug overdose in Utah was 15.5 per 100,000, putting the state above the national average of 14.9 per 100,000 (CDC, 2018b). Opioid overdose death rates in most of rural Utah far exceeds rates across the urban counties of the state. The higher rates of deaths in rural Utah is indeed concerning. Evidence indicates that rural areas are particularly hard hit due to limited access to care and resources (USDA, 2019).
Three kinds of medication-assisted treatment (MAT) approved for treatment of opioid use disorder (OUD) include: methadone, buprenorphine, and naltrexone (SAMHSA, 2019a). These medications block the euphoric effect of drugs, relieve cravings, and stabilize brain chemistry without the negative side effects of the previously abused drug (SAMHSA, 2019b). This fact sheet gives details about MAT for opioid use disorder.
Recommended Citation
DasGupta, Debasree; Fanning Madden, Erin; Sulzer, Sandra H.; Light, Timothy; Chapoose, Michelle; and Prevedel, Suzanne, "The Urban/Rural Divide in Access to Medication-Assisted Treatment for Opioid Use Disorder in Utah" (2020). All Current Publications. Paper 2098.
https://digitalcommons.usu.edu/extension_curall/2098
Included in
Chemicals and Drugs Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Other Rehabilitation and Therapy Commons, Public Health Commons